Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.
Several landmark phase 3 trials have demonstrated the efficacy and safety of NOACs reducing the risk of stroke and mortality in patients living with AFib, as well as VTE.3,4,5,6
Granger et al conducted a randomised, double-blind study comparing apixaban (5mg twice daily) with warfarin (target international normalised ratio [INR] 2.0 to...
1000’s of Clinical and CPD content compiled by Key Opinion Leaders and our expert medical editors.
Access to medical webinars and events
Access medical journals from industry leaders and expert medical editorials.
Please check your email for an activation mail. Click the activation link to activate your account
1000’s of Clinical and CPD content compiled by Key Opinion Leaders and our expert medical editors.
Access to medical webinars and events
Access medical journals from industry leaders and expert medical editorials.
All webinar details will be emailed to your email address.
Did you know, you can book future webinars with a single click if you register an account with Medical Academic.
Your webinar seat has been booked and all webinar details will be emailed to your registered email address
Future Medical Academic webinars can be booked with a single click, all with a Medical Academic account… and it’s FREE.
* (Required)
1000’s of Clinical and CPD content compiled by Key Opinion Leaders and our expert medical editors.
Access to medical webinars and events
Access medical journals from industry leaders and expert medical editorials.
Thank you for registering. You can now log in to your account.
* (Required)
Enter your registered email address to receive an OTP
A verification code will be sent to your email address. Please ensure that admin@medicalacademic.co.za is on your safe sender list.
Get the most out of Medical Academic by telling us your occupation. This helps us create more great content for you and the community.
